Alzheimer's disease (AD) is an onset and incurable neurodegenerative disorder that has
been linked to various genetic, environmental, and lifestyle factors. Recent research has revealed
several potential targets for drug development, such as the prevention of Aβ production and removal,
prevention of tau hyperphosphorylation, and keeping neurons alive. Drugs that target numerous ADrelated
variables have been developed, and early results are encouraging. This review provides a
concise map of the different receptor signaling pathways associated with Alzheimer's Disease, as
well as insight into drug design based on these pathways. It discusses the molecular mechanisms of
AD pathogenesis, such as oxidative stress, aging, Aβ turnover, thiol groups, and mitochondrial activities,
and their role in the disease. It also reviews the potential drug targets, in vivo active agents, and
docking studies done in AD and provides prospects for future drug development. This review intends
to provide more clarity on the molecular processes that occur in Alzheimer's patient's brains, which
can be of use in diagnosing and preventing the condition.